CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 134 enrolled
Drug / intervention
Povidone-Iodine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03305159
NCT03305159Phase 4Completed

Tolerance of Chlorhexidine Gluconate Versus Povidone Iodine Vaginal Cleansing Solution: a Randomized Control Trial

Northwestern University·interventional·Posted Oct 9, 2017·Updated Jun 27, 2019

In Brief

A Phase 4 clinical trial evaluating Povidone-Iodine and 4% Chlorhexidine Gluconate for Surgical Preparation of the Vagina. Completed, enrolled 134 participants across 1 site.

Detailed Summary

Conduct a randomized control study to compare the tolerance of 4% chlorhexidine gluconate/4% isopropyl alcohol versus povidone iodine vaginal cleansing solutions for surgical preparations of the vagina. Patients will be randomized to either control (povidone iodine) or experimental (chlorhexidine gluconate), and then be given a short survey prior to and immediately after surgery, and again 24-48 hours via phone asking them about the presence and severity of vaginal dryness, burning, itchiness, unusual vaginal discharge, and pain or burning with urination.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedOct 9, 2017
Enrollment StartAug 1, 2017
Primary CompletionApr 1, 2018
Study CompletionApr 15, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.7 years ago

Interventions

Povidone-Iodinedrug

Patients will receive povidone iodine for the surgical preparation of the vagina.

4% Chlorhexidine Gluconatedrug

Patients will receive 4% chlorhexidine gluconate for the surgical preparation of the vagina.